Singapore: Parexel International opened a new office in Shenyang, China. This location will support growing client demand for a broad range of clinical development capabilities in the country and throughout the Asia Pacific region. The... Read more
Singapore: Merck Serono and Quintiles have signed a new, five-year clinical development agreement. This strategic collaboration... Read more
Singapore: PRA, a leading clinical research organization, has received a $400,000 grant from the Kansas Bioscience Authority... Read more
Singapore: Trifecta Clinical joined the board of directors for the Asia Training Consortium (ATC), which is a group of pharmaceutical companies,... Read more
Singapore: Regenerative medicine company, Avita Medical, has initiated a multicenter randomized control study on the use of ReCell Spray-On... Read more
New Zealand's Health Committee submitted a 62-page report to New Zealand's Parliament making necessary recommendations to improve the existing... Read more
Dr Paul Hutchison, a healthcare professional and a parliamentarian from Hunua, New Zealand, has emerged as one-of-the-most influential individuals... Read more
New Zealand is taking steps to improve the environment surrounding the country's clinical trial domain. With no accurate records of revenues... Read more
Singapore: Quintiles has been recognized as one of the World's Best Multinational Workplaces by the Great Place to Work Institute, finishing... Read more
Dr Paul Hutchison is ushering in a new era in the history of New Zealand's healthcare sector. Dr Hutchison, a parliamentarian from Hunua,... Read more
Singapore: Australian drug development company, Biotron, has commenced a landmark phase II human trial of its lead antiviral drug candidate,... Read more
Singapore: Alchemia announced that the independent Data Safety Monitoring Board (DSMB) responsible for reviewing the safety data of Alchemia's... Read more
Survey Box
Subscribe to BioSpectrum Asia digital mag at an attractive price of US $49.99 a year
(Includes all 24 regular & special issues @ fortnightly frequency)
Australia
China
India
Japan
Korea
Malaysia
New Zealand 
Singapore
Taiwan
Thailand
